Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
- 23 September 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 111 (4), 868-886
- https://doi.org/10.1016/j.xphs.2021.09.030
Abstract
No abstract availableFunding Information
- Genentech
- American Association of Pharmaceutical Scientists
This publication has 123 references indexed in Scilit:
- Quality Control of Protein Crystal Suspensions Using Microflow Imaging and Flow CytometryJournal of Pharmaceutical Sciences, 2013
- Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled systemBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Protein Particulate Detection Issues in Biotherapeutics Development—Current StatusAAPS PharmSciTech, 2012
- Adsorption Behavior of a Surfactant and a Monoclonal Antibody to Sterilizing-Grade FiltersJournal of Pharmaceutical Sciences, 2010
- Factors influencing antibody stability at solid–liquid interfaces in a high shear environmentBiotechnology Progress, 2009
- Response of a concentrated monoclonal antibody formulation to high shearBiotechnology & Bioengineering, 2009
- Lyophilization Cycle Development for a High-Concentration Monoclonal Antibody Formulation Lacking a Crystalline Bulking AgentJournal of Pharmaceutical Sciences, 2007
- Partially Crystalline Systems in Lyophilization: II. Withstanding Collapse at High Primary Drying Temperatures and Impact on Protein Activity RecoveryJournal of Pharmaceutical Sciences, 2005
- The trials and tribulations of producing the first genetically engineered drugNature Reviews Drug Discovery, 2003
- Protein crystals and their stabilityJournal of Crystal Growth, 1992